Jürgen Götz on Aducanumab Approved to Treat Alzheimer’s Disease
COMMENT We are watching the approval of aducanumab with interest, given that we had cloned the antibody to evaluate whether a combination with therapeutic ultrasound would be more effective in clearing amyloid and improving cognitive functions in the APP23 mouse